Clinical Trial

Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach

Unknown
View on ClinicalTrials.gov →
Summary
Fetal growth restriction (FGR) is a serious complication in pregnancy that can lead to various adverse outcomes. It's classified into early-onset (before 32 weeks) and late-onset (after 32 weeks), with late-onset associated with long-term risks like hypoxemia and developmental delays. The study focuses on the role of inflammation in FGR, introducing new blood markers for better understanding and diagnosis. It also addresses the challenges of using advanced diagnostic tools in low-resource settings and explores the use of machine learning to predict FGR based on inflammatory markers, highlighting the potential of artificial intelligence in overcoming these challenges.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06372938
Lead Sponsor Ankara Etlik City Hospital
Conditions Fetal Growth Restriction, Inflammatory Response
Enrollment 240 participants
Start Date 2024-01-31
Primary Completion 2024-07-06 (estimated)
Study Completion 2024-07-20 (estimated)
Updated on ClinicalTrials.gov 2024-07-08